Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse.

Authors :: Kulkarni UP
Selvarajan S
Fouzia NA
Lionel S
Nair SC
Balasubramanian P
Mani T
Abraham A
George B
Mathews V
Source :: Blood cancer journal [Blood Cancer J] 2023 Jun 22; Vol. 13 (1), pp. 94. Date of Electronic Publication: 2023 Jun 22.
Publication Year :: 2023

Subjects :: Humans
Arsenic Trioxide adverse effects
Tretinoin therapeutic use
Recurrence
Oxides adverse effects
Leukemia, Promyelocytic, Acute complications
Leukemia, Promyelocytic, Acute drug therapy
Arsenicals adverse effects
Antineoplastic Agents therapeutic use

Full Text Access

Tools